Table 1:
Moderna | Pfizer | Combined | |
---|---|---|---|
Total Subjects for Longitudinal Study | 27 | 15 | 42 |
Average Time Post 2nd Dose to Max Ab | 22 days | 30 days | 24 days |
Average Maximum Antibody Level | 127 ng / ml | 124 ng / ml | 126 ng / ml |
Moderna | Pfizer | Combined | |
---|---|---|---|
Total Subjects for Longitudinal Study | 27 | 15 | 42 |
Average Time Post 2nd Dose to Max Ab | 22 days | 30 days | 24 days |
Average Maximum Antibody Level | 127 ng / ml | 124 ng / ml | 126 ng / ml |